Flurbiprofen axetil

氟比洛芬酯

Report date: 2022/03/07 18:10:36
NME

Base Information

Drug NameFlurbiprofen axetil
Drug Alias Name氟比洛芬脂Ropion凯芬FP-83
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsCancer PainPainPain, Postoperative
Global Approved IndicationsCancer PainPain, Postoperative
Approved Indications in ChinaCancer PainPain, Postoperative
Original Approved Country/TerritoryJapan
Original Approved Date1992/03/27
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Friendship Hospital Co LtdBeijing Tide Pharmaceutical Co LtdKaken Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer PainPainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeM01AE09M02AA19R02AX01 +[4] 
Related LinksKEGG